freya meds semaglutide Home | WHAT I WISH I KNEW

Wegovy (semaglutide) can now be offered to patients at risk of stroke or heart attack, under new guidance issued by the National Institute for health and Care Excellence (NICE)

It also encourages feelings of fullness, which can help reduce cravings and support consistent, long-term wellness as part of a balanced lifestyle

Despite different names, they contain the same active ingredient, serving similar therapeutic purposes.

The landscape of weight management has expanded with new research shedding light on hormones like GLP-1 (glucagon-like peptide-1) and innovative supplements like Curb by Modere

Tirzepatide (Zepbound/Mounjaro): A dual GLP-1/GIP receptor agonist undergoing evaluation for MASH after demonstrating significant liver fat reduction in studies.Retatrutide: A "triple agonist" targeting GLP-1, GIP, and glucagon (GCGR) receptors, which has shown "unprecedented" efficacy in weight loss and is being evaluated for metabolic diseases including MASH